UPDATE: Clovis Oncology (CLVS) Shares Spike to Session Highs Amid Chatter (GILD) (LLY)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
(Updated - September 20, 2016 3:00 PM EDT)
Clovis Oncology (Nasdaq: CLVS) shares spike to session highs.
UPDATE - Market chatter recently speculated that Clovis has been eyed as a potential target for Gilead Sciences (NASDAQ: GILD), though it isn't clear if Gilead has any interest.
Lilly (NYSE: LLY) has also been mentioned today.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clovis Oncology (CLVS) PT Raised to $86 as Stifel Adopts Takeout Valuation
- Stocks with Implied Volatility Movement
- iPath S&P 500 VIX ST Futures ETN (VXX) down 16c to 20.57
Create E-mail Alert Related CategoriesRumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!